Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry.
BMJ
; 313(7048): 33-5, 1996 Jul 06.
Article
en En
| MEDLINE
| ID: mdl-8664771
This is the third of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies regulating the supply of drugs, particularly licensing and reimbursement controls, price and profit regulation. Price and profit controls contain few incentives for improving cost effective use of drugs, and focus on cost containment and profitability of domestic industry. Carefully monitored economic evaluation could lead to improvements in efficiency and benefits to patients and the health care system.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Costos de los Medicamentos
/
Aprobación de Drogas
/
Seguro de Servicios Farmacéuticos
/
Cooperación Internacional
Tipo de estudio:
Health_economic_evaluation
Límite:
Humans
País/Región como asunto:
America do norte
/
Europa
Idioma:
En
Revista:
BMJ
Asunto de la revista:
MEDICINA
Año:
1996
Tipo del documento:
Article
Pais de publicación:
Reino Unido